ProMIS Neurosciences Inc. - 8-K Filing

ProMIS Neurosciences reports Q3 2026 net loss of $8.2 million and reaffirms Q1 2027 topline data timing for PRECISE-AD trial. (Items: 2.02 Results of Operations and Financial ConditionOn November 12, 2026, ProMIS Neurosciences Inc, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 12, 2026, 21:17 UTC

Tickers: $PMN

Read the full article at SEC EDGAR

Part of the story ProMIS Neurosciences Inc. - 8-K Filing (3 articles)

More Regulatory news

FACT II Acquisition Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:46 UTC
Marblegate Capital Corp - 10-Q Filing SEC EDGAR · November 12, 2026, 21:46 UTC
Greenland Mines Ltd - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
InspireMD, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
InspireMD, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
Pinnacle Acquisition Corp - 10-Q Filing SEC EDGAR · November 12, 2026, 21:45 UTC
SUTRO BIOPHARMA, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
Aeluma, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
ASTEC INDUSTRIES INC - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
Live Oak Bancshares, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:44 UTC